The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Mayo Clinic
Aulos Bioscience, Inc.
Kidney Cancer Research Bureau
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Hoffmann-La Roche
VM Oncology, LLC
Takeda
GI Innovation, Inc.
Incyte Corporation
Yuhan Corporation
NuCana plc
invoX Pharma Limited
Hutchmed
PureTech
Vaccinex Inc.
CJ Bioscience, Inc.
Nykode Therapeutics ASA
NextCure, Inc.
Salubris Biotherapeutics Inc
Purple Biotech Ltd.
NantCell, Inc.
Turning Point Therapeutics, Inc.
NextCure, Inc.
SQZ Biotechnologies
OncoResponse, Inc.
Nektar Therapeutics
Institut Bergonié
NKGen Biotech, Inc.
MultiVir, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kyowa Kirin Co., Ltd.